Patent Office To Drop Some Proposed Revisions To Patent Challenge Proceedings, Vidal Tells Congress

Not all PTAB changes floated in advanced notice of proposed rulemaking will be pursued, and the rule may be split into two, USPTO Director Vidal testifies. PhRMA, BIO, AAM criticize the proposals.